Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.42 |
| ▸ | ECE1 | P42892 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 5/20 | 0.37 |
| ▸ | ACE | P12821 | 2/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.35 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.35 |
| ▸ | FUCA1 | P04066 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5173963 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL10791497 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL29386171 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL5173973 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL29385408 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL29385929 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL29385198 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL10791516 | 1.00 | ALDH1A1 (0.42) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL8070171 | 0.92 | ALDH1A1 (0.48) | ALDH1A1LMNAMAPTPTGS2TDP1 | |
| SCHEMBL8070167 | 0.92 | ALDH1A1 (0.48) | ALDH1A1LMNAMAPTPTGS2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1127117-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | Amgen Inc., (US) | 2001-08-29 | — | — | EP | claimed |
| WO-2001018203-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2001-03-15 | — | — | WO | claimed |
| WO-2025109783-A1 | METHOD FOR ANALYZING ANTIBODY | 中外製薬株式会社 | 2025-05-30 | — | — | WO | disclosed |
| WO-2025070337-A1 | ANTI-MERTK AGONIST ANTIBODY, ANTI-MERTK BISPECIFIC ANTIBODY, AND USE THEREOF | アステラス製薬株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2024111657-A1 | METHOD FOR PRODUCING PROTEIN | 中外製薬株式会社 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024085166-A1 | USE OF ANTI-CLDN4-ANTI-CD137 BISPECIFIC ANTIBODY COMBINED WITH PD-1 SIGNAL INHIBITOR FOR CANCER TREATMENT | アステラス製薬株式会社 | 2024-04-25 | — | — | WO | disclosed |
| CN-114585651-A | Novel antigen binding molecular forms | 再生元制药公司 | 2022-06-03 | — | — | CN | disclosed |
| EP-1140136-A2 | COMPOSITIONS AND METHODS FOR THE PREVENTION OR TREATMENT OF CANCER AND BONE LOSS ASSOCIATED WITH CANCER | Amgen Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1127117-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | Amgen Inc., (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001017543-A2 | COMPOSITIONS AND METHODS FOR THE PREVENTION OR TREATMENT OF CANCER AND BONE LOSS ASSOCIATED WITH CANCER | AMGEN INC. (US) | 2001-03-15 | — | — | WO | disclosed |
| WO-2001018203-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2001-03-15 | — | — | WO | disclosed |